Copyright
©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11427-11441
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11427
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11427
Table 5 Subgroup analysis for gastrointestinal symptoms
Subgroup/measure | Intervention group | Control group | Between-group difference | ||||
Mean difference (95%CI) | P value | Mean difference (95%CI) | P value | Mean difference (95%CI) | P value | ||
Abdominal distension | |||||||
Gastric cancer (n = 28) | T1 | Reference | N/A | Reference | N/A | 0 (-0.5, 0.5) | 1.00 |
T2 | -0.1 (-0.7, 0.5) | 1.00 | 0.4 (0.1, 0.8) | 0.01 | -0.5 (-1.0, 0) | 0.04 | |
T3 | -0.7 (-1.3, -0.1) | 0.02 | 0.2 (-0.4, 0.8) | 1.00 | -0.9 (-1.3, -0.4) | < 0.001 | |
Colon cancer (n = 36) | T1 | Reference | N/A | Reference | N/A | -0.3 (-0.7, 0.1) | 0.17 |
T2 | -0.2 (-0.6, 0.2) | 0.56 | 0.5 (0.1, 0.9) | 0.003 | -1.0 (-1.4, -0.6) | < 0.001 | |
T3 | -0.7 (-1.0, -0.3) | < 0.001 | 0.2 (-0.5, 0.9) | 1.00 | -1.1 (-1.5, -0.7) | < 0.001 | |
Nausea | |||||||
Gastric cancer (n = 28) | T1 | Reference | N/A | Reference | N/A | 0.6 (0.1, 1.0) | 0.01 |
T2 | -0.9 (-1.1, -0.7) | < 0.001 | 0.2 (-0.2, 0.6) | 0.71 | -0.5 (-0.9, -0.1) | 0.009 | |
T3 | -1.3 (-1.8, -0.9) | < 0.001 | -0.4 (-0.9, 0.2) | 0.32 | -0.4 (-0.7, -0.1) | 0.01 | |
Colon cancer (n = 36) | T1 | Reference | N/A | Reference | N/A | -0.2 (-0.7, 0.3) | 0.38 |
T2 | -0.9 (-1.2, -0.5) | < 0.001 | -0.4 (-0.7, 0) | 0.04 | -0.5 (-0.8, -0.2) | 0.004 | |
T3 | -0.7 (-0.9, -0.4) | < 0.001 | -0.8 (-1.3, -0.2) | 0.003 | -0.3 (-0.5, -0.1) | 0.007 | |
Vomiting | |||||||
Gastric cancer (n = 28) | T1 | Reference | N/A | Reference | N/A | 0.2 (-0.3, 0.7) | 0.43 |
T2 | -0.3 (-0.7, 0) | 0.04 | 0.1 (-0.2, 0.3) | 1.00 | -0.2 (-0.7, 0.2) | 0.35 | |
T3 | -0.5 (-1.0, -0.1) | 0.02 | -0.2 (-0.6, 0.2) | 0.71 | -0.1 (-0.3, 0) | 0.13 | |
Colon cancer (n = 36) | T1 | Reference | N/A | Reference | N/A | -0.2 (-0.5, 0.2) | 0.37 |
T2 | -0.1 (-0.3, 0.1) | 0.067 | -0.2 (-0.4, 0.1) | 0.10 | -0.1 (-0.3, 0.1) | 0.44 | |
T3 | -0.2 (-0.4, 0.1) | 0.11 | -0.3 (-0.7, 0.1) | 0.15 | 0 (0, 0) | 1.00 | |
Fatigue | |||||||
Gastric cancer (n = 28) | T1 | Reference | N/A | Reference | N/A | -0.5 (-1.1, 0) | 0.06 |
T2 | -0.5 (-1.0, 0.1) | 0.07 | -0.1 (-0.5, 0.2) | 1.00 | -0.9 (-1.3, -0.5) | < 0.001 | |
T3 | -0.8 (-1.2, -0.5) | < 0.001 | -0.8 (-1.1, -0.5) | < 0.001 | -0.5 (-0.9, -0.2) | 0.003 | |
Colon cancer (n = 36) | T1 | Reference | N/A | Reference | N/A | -0.3 (-0.7, 0.2) | 0.28 |
T2 | -0.9 (-1.2, -0.6) | < 0.001 | -0.3 (-0.5, 0) | 0.06 | -0.9 (0.4, 1.4) | < 0.001 | |
T3 | -1.3 (-1.6, -1.0) | < 0.001 | -0.6 (-0.9, -0.3) | < 0.001 | -1.0 (-1.4, -0.6) | < 0.001 |
- Citation: Guo M, Wang M, Chen LL, Wei FJ, Li JE, Lu QX, Zhang L, Yang HX. Effect of intradermal needle therapy at combined acupoints on patients’ gastrointestinal function following surgery for gastrointestinal tumors. World J Clin Cases 2022; 10(31): 11427-11441
- URL: https://www.wjgnet.com/2307-8960/full/v10/i31/11427.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i31.11427